The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...

"All we are saying [to Novo Nordisk] is, Treat the American people the same way that you treat people all over the world.

Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today led the committee in a hearing to ...

Health-care company stocks fell as Novo Nordisk CEO Lars Fruergaard Jørgensen defended the prices of his company's megablockbuster obesity and Type 2 diabetes medicines under tough questioning on ...

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

Here are five key takeaways: During the hearing, Novo Nordisk CEO Lars Fruergaard Jørgensen attributed the high prices of drugs such as Ozempic and Wegovy to PBMs, arguing that "a high list price is ...

Sen. Bernie Sanders questions Novo Nordisk CEO Lars Jorgensen in a hearing on Capitol Hill about the high prices Americans ...

Senate Republicans say they don’t want to get sucked into another messy fight over ObamaCare and are trying to wave away ...